These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 33352357)

  • 1. Fingolimod treatment reverses signs of diffuse white matter damage in multiple sclerosis: A pilot study.
    Saraste M; Bezukladova S; Sucksdorff M; Saunavaara V; Rissanen E; Matilainen M; Airas L
    Mult Scler Relat Disord; 2021 Feb; 48():102690. PubMed ID: 33352357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal MRI Response to Fingolimod in Multiple Sclerosis: A Nonrandomized, Single Arm, Observational Study.
    Bernitsas E; Kopinsky H; Lichtman-Mikol S; Razmjou S; Santiago-Martinez C; Yarraguntla K; Bao F
    J Neuroimaging; 2021 Mar; 31(2):379-387. PubMed ID: 33368776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum glial fibrillary acidic protein associates with microstructural white matter damage in multiple sclerosis: GFAP and DTI.
    Saraste M; Bezukladova S; Matilainen M; Sucksdorff M; Kuhle J; Leppert D; Airas L
    Mult Scler Relat Disord; 2021 May; 50():102810. PubMed ID: 33556656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fingolimod-improved axonal and myelin integrity of white matter tracts associated with multiple sclerosis-related functional impairments.
    Gurevich M; Waknin R; Stone E; Achiron A
    CNS Neurosci Ther; 2018 May; 24(5):412-419. PubMed ID: 29316271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of switching from glatiramer acetate 20 mg/daily to glatiramer acetate 40 mg three times a week on gray and white matter pathology in subjects with relapsing multiple sclerosis: A longitudinal DTI study.
    Zivadinov R; Bergsland N; Hagemeier J; Tavazzi E; Ramasamy DP; Durfee J; Cherneva M; Carl E; Carl J; Kolb C; Hojnacki D; Weinstock-Guttman B
    J Neurol Sci; 2018 Apr; 387():152-156. PubMed ID: 29571854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion Tensor Imaging Revealed Microstructural Changes in Normal-Appearing White Matter Regions in Relapsing-Remitting Multiple Sclerosis.
    Bao J; Tu H; Li Y; Sun J; Hu Z; Zhang F; Li J
    Front Neurosci; 2022; 16():837452. PubMed ID: 35310094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of longitudinal DTI metrics in MS with treatment of injectables, fingolimod and dimethyl fumarate.
    Alshehri A; Al-Iedani O; Koussis N; Khormi I; Lea R; Lechner-Scott J; Ramadan S
    Neuroradiol J; 2023 Aug; 36(4):388-396. PubMed ID: 36395524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into disseminated MS brain pathology with multimodal diffusion tensor and PET imaging.
    Bezukladova S; Tuisku J; Matilainen M; Vuorimaa A; Nylund M; Smith S; Sucksdorff M; Mohammadian M; Saunavaara V; Laaksonen S; Rokka J; Rinne JO; Rissanen E; Airas L
    Neurol Neuroimmunol Neuroinflamm; 2020 May; 7(3):. PubMed ID: 32123046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of diffusion tensor imaging (DTI) tissue characterization parameters in white matter tracts of patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD).
    Chen X; Roberts N; Zheng Q; Peng Y; Han Y; Luo Q; Feng J; Luo T; Li Y
    Eur Radiol; 2024 Aug; 34(8):5263-5275. PubMed ID: 38175221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of normal-appearing white matter in multiple sclerosis using quantitative susceptibility mapping in conjunction with diffusion tensor imaging.
    Yu FF; Chiang FL; Stephens N; Huang SY; Bilgic B; Tantiwongkosi B; Romero R
    Neuroradiology; 2019 Jan; 61(1):71-79. PubMed ID: 30539215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microstructural alterations in different types of lesions and their perilesional white matter in relapsing-remitting multiple sclerosis based on diffusion kurtosis imaging.
    Shi Z; Pan Y; Yan Z; Ding S; Hu H; Wei Y; Luo D; Xu Y; Zhu Q; Li Y
    Mult Scler Relat Disord; 2023 Mar; 71():104572. PubMed ID: 36821979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review of microstructural abnormalities in multiple sclerosis detected with NODDI and DTI models of diffusion-weighted magnetic resonance imaging.
    Caranova M; Soares JF; Batista S; Castelo-Branco M; Duarte JV
    Magn Reson Imaging; 2023 Dec; 104():61-71. PubMed ID: 37775062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T1/T2 ratio: A quantitative sensitive marker of brain tissue integrity in multiple sclerosis.
    Hannoun S; Kocevar G; Codjia P; Barile B; Cotton F; Durand-Dubief F; Sappey-Marinier D
    J Neuroimaging; 2022 Mar; 32(2):328-336. PubMed ID: 34752685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neural diffusion tensor imaging metrics correlate with clinical measures in people with relapsing-remitting MS.
    Alshehri A; Al-Iedani O; Arm J; Gholizadeh N; Billiet T; Lea R; Lechner-Scott J; Ramadan S
    Neuroradiol J; 2022 Oct; 35(5):592-599. PubMed ID: 35118885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum neurofilament light chain correlates with myelin and axonal magnetic resonance imaging markers in multiple sclerosis.
    Yik JT; Becquart P; Gill J; Petkau J; Traboulsee A; Carruthers R; Kolind SH; Devonshire V; Sayao AL; Schabas A; Tam R; Moore GRW; Li DKB; Stukas S; Wellington C; Quandt JA; Vavasour IM; Laule C
    Mult Scler Relat Disord; 2022 Jan; 57():103366. PubMed ID: 35158472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion tensor imaging changes of the cortico-thalamic-striatal tracts correlate with fatigue and disability in people with relapsing-remitting MS.
    Alshehri A; Koussis N; Al-Iedani O; Arm J; Khormi I; Lea S; Lea R; Ramadan S; Lechner-Scott J
    Eur J Radiol; 2024 Jan; 170():111207. PubMed ID: 37988961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of normal-appearing white matter tract integrity in multiple sclerosis: a diffusion kurtosis imaging study.
    de Kouchkovsky I; Fieremans E; Fleysher L; Herbert J; Grossman RI; Inglese M
    J Neurol; 2016 Jun; 263(6):1146-55. PubMed ID: 27094571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High serum neurofilament associates with diffuse white matter damage in MS.
    Saraste M; Bezukladova S; Matilainen M; Tuisku J; Rissanen E; Sucksdorff M; Laaksonen S; Vuorimaa A; Kuhle J; Leppert D; Airas L
    Neurol Neuroimmunol Neuroinflamm; 2021 Jan; 8(1):. PubMed ID: 33293460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal microstructural MRI markers of demyelination and neurodegeneration in early relapsing-remitting multiple sclerosis: Magnetisation transfer, water diffusion and g-ratio.
    York EN; Meijboom R; Thrippleton MJ; Bastin ME; Kampaite A; White N; Chandran S; Waldman AD;
    Neuroimage Clin; 2022; 36():103228. PubMed ID: 36265199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of patients with relapsing-remitting multiple sclerosis using tract-based spatial statistics analysis: diffusion kurtosis imaging.
    Li HQ; Yin B; Quan C; Geng DY; Yu H; Bao YF; Liu J; Li YX
    BMC Neurol; 2018 Aug; 18(1):108. PubMed ID: 30086721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.